Specialty Pharmacy

The drug was previously approved to treat HCV in adults

Researchers in Australia tested blood samples at 4 different time points in an otherwise healthy adult woman who presented with COVID-19 and had mild-to-moderate symptoms requiring hospital admission.

Now is the time for pharmacists to stand even taller and provide more help to their communities.

A new study shows that the advantages of digital breast tomosynthesis are maintained over multiple years and rounds of screening compared with digital mammography.

A clinical program evaluating sarilumab (Kevzara, Sanofi and Regeneron) has started in patients hospitalized with a severe form of the novel coronavirus (COVID-19), according to the company.

A growth hormone known as insulin-like growth factor-1 has been found to play a role in the development of breast cancer.

Top news from across the health care landscape.

Top news from across the health care landscape.

Top news of the week from Directions in Specialty PharmacyTM.

New research shows targeting stromal cells may be an effective way of overcoming resistance to chemotherapy and radiation in patients with glioblastoma, a deadly brain cancer.

A bipartisan coalition in Congress has introduced new legislation designed to ensure Medicare patients have access to Part B home infusion medications.

The FDA has approved nivolumab plus ipilimumab injections for intravenous use to treat hepatocellular carcinoma in patients who have been previously treated with sorafenib.

Top news from across the health care landscape.

Novel approaches such as telemedicine may be a way to reach rural patients with cancer, according to a panel discussion at the Hematology/Oncology Pharmacists Association 2020 Meeting

Lesbian, gay, bisexual, transgender, and queer (LGBTQ) patients with cancer face specific barriers when seeking medical care, but pharmacists and other medical professionals can take specific steps to reduce the gaps in care.

Top news of the week across the healthcare landscape.

Due to the uniqueness of each disease state and motivations of each player in the market to capture revenue from the growing industry, there is an abundance of specialty pharmacy solutions available in the market.

Top news from across the health care landscape.

Levitating human plasma may lead to simpler detection of diseases and the development of addiction to substances such as opioids.

Chronic fibrosing ILD with a progressive phenotype encompasses a group of fibrotic lung diseases caused by various underlying diseases or conditions.

Top news from across the health care landscape.

The FDA also granted osilodrostat orphan drug designation.

Treatment with cord blood-derived chimeric antigen receptor natural killer-cell therapy targeting CD19 resulted in clinical responses in relapsed or refractory non-Hodgkin’s lymphoma and chronic lymphocytic leukemia.

Top News of the Week from Directions in Specialty Pharmacy

Top news from across the health care landscape.

A study offers evidence that chimeric antigen receptor T-cell therapy may not only extend patients’ survival, but also improve their quality of life after treatment.

Top news from across the health care landscape.

AL101 is a potent, selective, injectable small molecule gamma secretase inhibitor and was granted Orphan Drug designation in May 2019 for the treatment of ACC.

Pharmacists should be aware of what drug repurposing is and how it occurs as due to the vast amount of opportunities that exist.

Top news from across the health care landscape.